Welcome to Fresenius SE
Fresenius is a global health care group with products and services for dialysis, the hospital and the medical care of patients at home.
The Fresenius Group consists of the following four business segments that are responsible for their own business operations worldwide: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed.
Latest News
30.04.2008
Fresenius Medical Care Reports Strong Start For 2008 and Confirms Outlook for Full Year (for additional tables see PDF-file)Fresenius Medical Care AG & Co. KGaA, the world’s largest provider of Dialysis Products and Services, today announced its results for the first quarter of 2008. >>>
30.04.2008
Fresenius SE: Q1 2008 - Successful start into 2008 (for additional tables see PDF-file)Outlook for 2008 confirmed >>>
20.04.2008
Fresenius Kabi strengthens its position in i.v. drugs by acquiring Dabur Pharma, a leading manufacturer of oncology genericsFresenius Kabi, a business segment of health care group Fresenius, continues its growth strategy in intravenously administered drugs (i.v. drugs). The company today announced the acquisition of 73.3 % of the share capital of the Indian company Dabur Pharma Ltd. for a price of INR 8,782 million (€ 139 million) or INR 76.50 per share in cash. >>>
07.04.2008
Fresenius Medical Care announces status in Patent CaseFresenius Medical Care AG & Co. KGaA (“The Company”) today announced that the United States District Court for the Northern District of California issued orders in the long standing patent case initiated by the Company to establish the invalidity of certain patents claims alleged to apply to the Company’s 2008K hemodialysis machines in United States. >>>
02.04.2008
Fresenius Medical Care Announces upgraded Rating of Unsecured Debt Issues by Standard & Poor’sFresenius Medical Care AG & Co. KGaA (“the Company”), the world’s largest provider of Dialysis Products and Services, today reports that Standard & Poor’s has assigned upgraded debt and recovery ratings to the Company’s unsecured debt issues. >>>